|
業務類別
|
Biotechnology |
|
業務概覽
|
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively havethe potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. |
| 公司地址
| 42127 Pleasant Forest Court, Ashburn, VA, USA, 20148-7349 |
| 電話號碼
| +1 703 980-4182 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.quoinpharma.com |
| 員工數量
| 6 |
| Dr. Michael Myers, PhD |
Chairman of the Board and Chief Executive Officer |
美元 745.28K |
16/07/2026 |
| Ms. Denise Carter |
Director and Chief Operating Officer |
美元 595.44K |
16/07/2026 |
| Ms. Bridget Sally Lawlor |
Chief Financial Officer |
美元 165.21K |
16/07/2026 |
|
|
| Dr. Dennis H. Langer, J.D.,M.D. |
Independent Director |
16/07/2026 |
| Mr. Joseph P. Cooper |
Independent Director |
16/07/2026 |
| Mr. Anthony James Culverwell |
Independent Director |
16/07/2026 |
| Dr. Michael Myers, PhD |
Chairman of the Board and Chief Executive Officer |
16/07/2026 |
| Ms. Denise Carter |
Director and Chief Operating Officer |
16/07/2026 |
| Ms. Natalie Leong |
Independent Director |
16/07/2026 |
| Mr. Michael Sember |
Independent Director |
16/07/2026 |
|
|
|
|
